ANTC.F Stock Overview
Engages in the health and wellness business in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Aion Therapeutic Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.011 |
| 52 Week High | CA$0.048 |
| 52 Week Low | CA$0.0035 |
| Beta | 0.53 |
| 11 Month Change | -7.08% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -47.50% |
| 5 Year Change | n/a |
| Change since IPO | -88.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| ANTC.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 84.2% | 1.6% | 2.2% |
| 1Y | n/a | 10.0% | 31.7% |
Return vs Industry: Insufficient data to determine how ANTC.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ANTC.F performed against the US Market.
Price Volatility
| ANTC.F volatility | |
|---|---|
| ANTC.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ANTC.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ANTC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | John Simmonds | n/a |
Aion Therapeutic Inc. engages in the health and wellness business in the United States. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is based in Vancouver, Canada.
Aion Therapeutic Inc. Fundamentals Summary
| ANTC.F fundamental statistics | |
|---|---|
| Market cap | US$5.19m |
| Earnings (TTM) | -US$4.53m |
| Revenue (TTM) | US$573.74k |
9.0x
P/S Ratio-1.1x
P/E RatioIs ANTC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANTC.F income statement (TTM) | |
|---|---|
| Revenue | CA$802.34k |
| Cost of Revenue | CA$445.81k |
| Gross Profit | CA$356.53k |
| Other Expenses | CA$6.69m |
| Earnings | -CA$6.33m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 44.44% |
| Net Profit Margin | -788.87% |
| Debt/Equity Ratio | -60.5% |
How did ANTC.F perform over the long term?
See historical performance and comparison